EUVIMEDEUVIMED entdecken
Crossref

Expression of CD44s and CD44v6 in Lung Cancer and Their Correlation with Prognostic Factors

Alaa M Afify, Stacey Tate, Blythe Durbin-Johnson, David M Rocke, Thomas Konia

The International Journal of Biological Markers · 2011-01 · 26 (1) · 50-57

DOI: 10.5301/jbm.2011.6291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The International Journal of Biological Markers, online erschienen am 13.03.2018. Verfasst von Alaa M Afify und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pathology and Laboratory Medicine, University of California Davis Health System, Sacramento, CA 95817, USA. alaa.afify@ucdmc.uc…. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

CD44, a transmembrane glycoprotein receptor, plays a major role in tumor progression and metastasis.

Objective

To evaluate the expression of CD44 standard (CD44s) and its variant 6 (CD44v6) in normal and neoplastic lung tissue and correlate it with prognostic factors in lung cancer.

Methods

The study included 52 non-small cell lung carcinomas (NSCLC) (21 squamous cell carcinomas and 31 adenocarcinomas), 15 small cell lung carcinomas (SCLC) and 8 carcinoid tumors. Expression of CD44s and CD44v6 was evaluated by immunohistochemistry and correlated with lung cancer prognostic factors.

Results

All squamous cell carcinomas expressed both CD44s and CD44v6. Adenocarcinomas expressed CD44s in 39% of cases and CD44v6 in 45%. Carcinoid tumors expressed only CD44s in 88% of cases. All SCLCS were negative for both CD44s and CD44v6. A restricted panel consisting of CD44s and CD44v6 will discriminate NSCLC from SCLC with a sensitivity of 67% and a specificity of 100%. In adenocarcinoma CD44s expression was significantly correlated with lymph node metastases (p=0.007) while CD44v6 expression was more significantly associated with tumor size (p=0.0032).

Conclusions

CD44s and CD44v6 are expressed in certain types of lung cancer. In adenocarcinoma CD44s and CD44v6 expression is significantly correlated with lymph node metastases and tumor size.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorescent Antibody TechniqueHumansHyaluronan ReceptorsLung NeoplasmsLymphatic MetastasisPrognosisRetrospective Studies

Substanzen

CD44 protein, humanHyaluronan Receptors

Autor:innen und Institutionen

  • Department of Medical Pathology and Laboratory Medicine, University of California Davis Health System, Sacramento, CA 95817, USA. alaa.afify@ucdmc.ucdavis.edu

Förderung

  • NCRR NIH HHS

Zitieren

APA

Afify, A. M., Tate, S., Durbin-Johnson, B., Rocke, D. M., & Konia, T. (2011). Expression of CD44s and CD44v6 in Lung Cancer and Their Correlation with Prognostic Factors. The International Journal of Biological Markers, 26(1), 50-57. https://doi.org/10.5301/jbm.2011.6291

Vancouver

Afify AM, Tate S, Durbin-Johnson B, Rocke DM, Konia T. Expression of CD44s and CD44v6 in Lung Cancer and Their Correlation with Prognostic Factors. The International Journal of Biological Markers. 2011;26(1):50-57. doi:10.5301/jbm.2011.6291

BibTeX
@article{Afify2011,
  author = {Afify, Alaa M and Tate, Stacey and Durbin-Johnson, Blythe and Rocke, David M and Konia, Thomas},
  title = {Expression of CD44s and CD44v6 in Lung Cancer and Their Correlation with Prognostic Factors},
  journal = {The International Journal of Biological Markers},
  year = {2011},
  volume = {26},
  number = {1},
  pages = {50--57},
  doi = {10.5301/jbm.2011.6291}
}
Kostenlos starten →